204 related articles for article (PubMed ID: 18980241)
1. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Dec; 105(6):1501-6. PubMed ID: 18980241
[TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
[TBL] [Abstract][Full Text] [Related]
3. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B.
Kim H; Lee HS; Chang KT; Ko TH; Baek KJ; Kwon NS
J Immunol; 1995 May; 154(9):4741-8. PubMed ID: 7536778
[TBL] [Abstract][Full Text] [Related]
4. The serine protease inhibitors TLCK and TPCK inhibit the in vitro immortalization of primary human keratinocytes by HPV-18 DNA.
Stöppler H; Koval D; Schlegel R
Oncogene; 1996 Oct; 13(7):1545-8. PubMed ID: 8875993
[TBL] [Abstract][Full Text] [Related]
5. Involvement of TLCK-sensitive serine protease in colchicine-induced cell death of sympathetic neurons in culture.
Mitsui C; Sakai K; Ninomiya T; Koike T
J Neurosci Res; 2001 Nov; 66(4):601-11. PubMed ID: 11746380
[TBL] [Abstract][Full Text] [Related]
6. N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) suppresses neuritic degeneration caused by different experimental paradigms including in vitro Wallerian degeneration.
Ikegami K; Kato S; Koike T
Brain Res; 2004 Dec; 1030(1):81-93. PubMed ID: 15567340
[TBL] [Abstract][Full Text] [Related]
7. High and low molecular weight DNA cleavage in ovarian granulosa cells: characterization and protease modulation in intact cells and in cell-free nuclear autodigestion assays.
Trbovich AM; Hughes FM; Perez GI; Kugu K; Tilly KI; Cidlowski JA; Tilly JL
Cell Death Differ; 1998 Jan; 5(1):38-49. PubMed ID: 10200444
[TBL] [Abstract][Full Text] [Related]
8. A role for serine proteases in mediating phorbol ester-induced differentiation of HL-60 cells.
Bestilny LJ; Riabowol KT
Exp Cell Res; 2000 Apr; 256(1):264-71. PubMed ID: 10739673
[TBL] [Abstract][Full Text] [Related]
9. The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation.
Sané AT; Schmitt E; Steyaert A; Meyer D; Bertrand R
Biochem Cell Biol; 1997; 75(4):359-68. PubMed ID: 9493958
[TBL] [Abstract][Full Text] [Related]
10. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
Hughes FM; Evans-Storms RB; Cidlowski JA
Cell Death Differ; 1998 Dec; 5(12):1017-27. PubMed ID: 9894608
[TBL] [Abstract][Full Text] [Related]
11. Proteinase inhibitors TPCK and TLCK prevent Entamoeba histolytica induced disturbance of tight junctions and microvilli in enteric cell layers in vitro.
Lauwaet T; Oliveira MJ; Callewaert B; De Bruyne G; Mareel M; Leroy A
Int J Parasitol; 2004 Jun; 34(7):785-94. PubMed ID: 15157761
[TBL] [Abstract][Full Text] [Related]
12. Effect of serine protease inhibitors on posttraumatic brain injury and neuronal apoptosis.
Movsesyan VA; Yakovlev AG; Fan L; Faden AI
Exp Neurol; 2001 Feb; 167(2):366-75. PubMed ID: 11161625
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine blocks apoptosis induced by N-alpha-tosyl-L-phenylalanine chloromethyl ketone in transformed T-cells.
Heussler VT; Fernandez PC; Machado J; Botteron C; Dobbelaere DA
Cell Death Differ; 1999 Apr; 6(4):342-50. PubMed ID: 10381628
[TBL] [Abstract][Full Text] [Related]
14. DNA degradation and proteolysis in thymocyte apoptosis.
Fearnhead HO; MacFarlane M; Dinsdale D; Cohen GM
Toxicol Lett; 1995 Dec; 82-83():135-41. PubMed ID: 8597041
[TBL] [Abstract][Full Text] [Related]
15. Activation of chymotrypsin-like serine protease(s) during apoptosis detected by affinity-labeling of the enzymatic center with fluoresceinated inhibitor.
Grabarek J; Dragan M; Lee BW; Johnson GL; Darzynkiewicz Z
Int J Oncol; 2002 Feb; 20(2):225-33. PubMed ID: 11788882
[TBL] [Abstract][Full Text] [Related]
16. The serine protease inhibitors, tosylphenylalanine chloromethyl ketone and tosyllysine chloromethyl ketone, potently inhibit pp70s6k activation.
Grammer TC; Blenis J
J Biol Chem; 1996 Sep; 271(39):23650-2. PubMed ID: 8798584
[TBL] [Abstract][Full Text] [Related]
17. Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells.
Kimura K; Markowski M; Edsall LC; Spiegel S; Gelmann EP
Cell Death Differ; 2003 Feb; 10(2):240-8. PubMed ID: 12700652
[TBL] [Abstract][Full Text] [Related]
18. The characterization of cell death induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd) in FM3A cells.
Takatori S; Tsutsumi S; Hidaka M; Kanda H; Matsuda A; Fukushima M; Wataya Y
Nucleosides Nucleotides; 1998 Aug; 17(8):1309-17. PubMed ID: 9672699
[TBL] [Abstract][Full Text] [Related]
19. Pro- and anti-apoptotic effects of an inhibitor of chymotrypsin-like serine proteases.
King MA; Halicka HD; Darzynkiewicz Z
Cell Cycle; 2004 Dec; 3(12):1566-71. PubMed ID: 15539954
[TBL] [Abstract][Full Text] [Related]
20. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.
Stöppler H; Stöppler MC; Adduci A; Koval D; Schlegel R
Virology; 1996 Mar; 217(2):542-53. PubMed ID: 8610446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]